Tech Company Financing Transactions
Saluda Medical Funding Round
Saluda Medical closed a $100 million investment round on 1/13/2025. Investors included Redmile Group, Action Potential Venture Capital and Fidelity Management & Research Company.
Transaction Overview
Company Name
Announced On
1/13/2025
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance the commercialization of the Evoke® System, the first commercial application of its proprietary closed-loop, dose-control neuromodulation platform.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
9401 James Ave S 132
Bloomington, MN 55431
USA
Bloomington, MN 55431
USA
Phone
Undisclosed
Website
Email Address
Overview
We have developed a novel neuromodulation platform designed to measure a patient's unique biomarkers for the treatment of chronic neurological conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jim Schuermann
Browse more venture capital transactions:
Prev: 1/13/2025: Aerin Medical venture capital transaction
Next: 1/13/2025: Kardigan venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. All VC database entries on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs